Japan Panels Agree to Add Myocarditis as ADRs for Pfizer, Moderna Vaccines

To read the full story

• Sign In
• Subscribe

Related Article

• No Major Safety Concerns for COVID-19 Jabs: MHLW Panels
  January 24, 2022

• Second Case of TTS with Possible Link to AstraZeneca COVID-19 Vaccine Reported in Japan
  December 27, 2021

• TTS with Possible Link to AstraZeneca COVID-19 Vaccine Reported in Japan
  November 15, 2021

• MHLW Panels Continue to See No Major Safety Concerns for COVID-19 Jabs
  October 25, 2021

• No Major Safety Concerns for Moderna, Pfizer COVID-19 Vaccines: MHLW Panels
  October 4, 2021

• Tainted Moderna Jabs Run Afoul of PMD Law: Minister
  September 16, 2021

• Causal Link between Deaths and Recalled Batch of Moderna Jab “Indeterminable”
  September 13, 2021

• Systemic Symptoms Unlikely to Occur from Contaminated Moderna Jabs: Japan Vaccinology Society
  September 9, 2021

• Post-Vaccination Death Cases Being Investigated with Integrity: Takeda
  September 8, 2021

• Takeda Recalling Suspended Batches of Moderna Jabs in Japan; Administrative Action Possible
  September 2, 2021

• No Major Safety Concerns for Moderna, Pfizer COVID-19 Vaccines: MHLW
  August 6, 2021

• Label Revisions Ordered for AstraZeneca’s COVID-19 Vaccine; Thrombocytopenia Added to Adverse Reactions
  July 28, 2021

• Panels Agree to Add Risk of Thrombocytopenia to AstraZeneca Vaccine Label
  July 27, 2021

• No Major Safety Concerns for Moderna, Pfizer COVID-19 Vaccines: MHLW
  July 9, 2021

• No Major Concerns over Safety of Moderna, Pfizer COVID-19 Vaccines: MHLW
  June 11, 2021

• MHLW Panels to Analyze Group-Based Data for Post-COVID-19 Vaccination Deaths
  May 27, 2021

• No Serious Safety Concerns Detected for Comirnaty: MHLW Safety Panels
  May 14, 2021

• Don’t Take Vaccines If You Feel Ill: Safety Panels to Elderly
  April 26, 2021

• COVID-19 Vaccine Reactions More Common in Women, Younger People: MHLW Study
  April 12, 2021

• Vaccine Safety Panels to Evaluate Suspected Anaphylaxis Cases Based on Pfizer’s Reports
  April 12, 2021

• 35.6% of Pfizer Vaccine Recipients Developed Fevers after 2nd Shot, Higher Incidence in Women: MHLW
  March 29, 2021

• No Significant Concerns Observed with Pfizer COVID-19 Vaccine: Japan Safety Panels
  March 15, 2021

• Site Pain Common with COVID-19 Vaccine, but It Improves in 3 Days: Safety Follow-Up
  March 15, 2021

• Japan Confirms 1st Case of Anaphylaxis from COVID-19 Vaccination
  March 8, 2021

• Woman Dies 3 Days after COVID-19 Vaccine Shot, but Link Indeterminable
  March 3, 2021